Literature DB >> 21564549

Enzymatic features of the glucose metabolism in tumor cells.

Anique Herling1, Matthias König, Sascha Bulik, Hermann-Georg Holzhütter.   

Abstract

Many tumor types exhibit an impaired Pasteur effect, i.e. despite the presence of oxygen, glucose is consumed at an extraordinarily high rate compared with the tissue from which they originate - the so-called 'Warburg effect'. Glucose has to serve as the source for a diverse array of cellular functions, including energy production, synthesis of nucleotides and lipids, membrane synthesis and generation of redox equivalents for antioxidative defense. Tumor cells acquire specific enzyme-regulatory mechanisms to direct the main flux of glucose carbons to those pathways most urgently required under challenging external conditions such as varying substrate availability, presence of anti-cancer drugs or different phases of the cell cycle. In this review we summarize the currently available information on tumor-specific expression, activity and kinetic properties of enzymes involved in the main pathways of glucose metabolism with due regard to the explanation of the regulatory basis and physiological significance of the Warburg effect. We conclude that, besides the expression level of the metabolic enzymes involved in the glucose metabolism of tumor cells, the unique tumor-specific pattern of isozymes and accompanying changes in the metabolic regulation below the translation level enable tumor cells to drain selfishly the blood glucose pool that non-transformed cells use as sparingly as possible.
© 2011 The Authors Journal compilation © 2011 FEBS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21564549     DOI: 10.1111/j.1742-4658.2011.08174.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  21 in total

1.  Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo.

Authors:  Albert A De Vera; Pranav Gupta; Zining Lei; Dan Liao; Silpa Narayanan; Qiuxu Teng; Sandra E Reznik; Zhe-Sheng Chen
Journal:  Cancer Lett       Date:  2018-11-01       Impact factor: 8.679

2.  Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancer.

Authors:  Yun-Kai Zhang; Yi-Jun Wang; Zi-Ning Lei; Guan-Nan Zhang; Xiao-Yu Zhang; De-Shen Wang; Sweilem B Al-Rihani; Suneet Shukla; Suresh V Ambudkar; Amal Kaddoumi; Zhi Shi; Zhe-Sheng Chen
Journal:  Cancer Lett       Date:  2018-10-28       Impact factor: 8.679

Review 3.  Dysregulated pH in Tumor Microenvironment Checkmates Cancer Therapy.

Authors:  Jaleh Barar; Yadollah Omidi
Journal:  Bioimpacts       Date:  2013-12-10

4.  Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer.

Authors:  F Graziano; A Ruzzo; E Giacomini; T Ricciardi; G Aprile; F Loupakis; P Lorenzini; E Ongaro; F Zoratto; V Catalano; D Sarti; E Rulli; C Cremolini; M De Nictolis; G De Maglio; A Falcone; G Fiorentini; M Magnani
Journal:  Pharmacogenomics J       Date:  2016-03-01       Impact factor: 3.550

Review 5.  A Metabolic Therapy for Malignant Glioma Requires a Clinical Measure.

Authors:  Zachary Corbin; Daniel Spielman; Lawrence Recht
Journal:  Curr Oncol Rep       Date:  2017-11-02       Impact factor: 5.075

6.  Manipulation of tumor metabolism for therapeutic approaches: ovarian cancer-derived cell lines as a model system.

Authors:  Kristina Goetze; Christian G Fabian; Andrea Siebers; Livia Binz; Daniel Faber; Stefano Indraccolo; Giorgia Nardo; Ulrike G A Sattler; Wolfgang Mueller-Klieser
Journal:  Cell Oncol (Dordr)       Date:  2015-08-19       Impact factor: 6.730

7.  Investigation of glucose catabolism in hypoxic Mcf 7 breast cancer culture.

Authors:  İrem Bayar; Ayşegül Bildik
Journal:  Cytotechnology       Date:  2021-02-20       Impact factor: 2.058

8.  The Amazing Power of Cancer Cells to Recapitulate Extraembryonic Functions: The Cuckoo's Tricks.

Authors:  Jose-Ignacio Arias; Maria-Angeles Aller; Isabel Prieto; Ana Arias; Zoe de Julian; Heping Yang; Jaime Arias
Journal:  J Oncol       Date:  2011-09-28       Impact factor: 4.375

9.  Assessing and utilizing esterase specificity in antimicrobial prodrug development.

Authors:  Kenton J Hetrick; Ronald T Raines
Journal:  Methods Enzymol       Date:  2021-12-23       Impact factor: 1.682

Review 10.  Glucose Metabolism in Burns-What Happens?

Authors:  Silviu Constantin Badoiu; Daniela Miricescu; Iulia-Ioana Stanescu-Spinu; Alexandra Ripszky Totan; Silvia Elena Badoiu; Michel Costagliola; Maria Greabu
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.